» Articles » PMID: 32231452

The Clinical Characteristics of Fascioliasis in Pediatric Patients

Overview
Publisher Kare Publishing
Specialty Pediatrics
Date 2020 Apr 2
PMID 32231452
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Fascioliasis is a trematode flatworm infection caused by and is mesoendemic in Turkey. Six cases of pediatric fascioliasis are presented here. All patients had histories of consumption of various raw vegetables. Four of our patients were at the hepatic phase, and two were at the biliary phase. Except for one patient, all patients had eosinophilia. In three patients, total IgE levels were markedly increased. In these patients, there was an eosinophilic leukomoid reaction accompanied by a high total IgE level. Except for one of our patients, all patients had positive indirect hemagglutination tests. This patient was diagnosed as having fascioliasis with a compatible clinical picture. Except one, all of our patients were completely treated with a single-treatment regimen of triclabendazole; one patient needed re-administration. Only in patient 1, liver enzymes increased after triclabendazole administration because he had taken the medication for longer than prescribed by mistake. The elevation of liver enzymes was not observed in the other patients who received the correct dose. All patients recovered completely with triclabendazole treatment. The patients' dietary habits, eosinophilia, and markedly elevated IgE levels may be significant predictors for physicians to suspect fascioliasis.

Citing Articles

Characteristics of Hepatobiliary Fascioliasis and the Role of Endoscopic Retrograde Cholangiopancreatography in Management: A Single Center Experience.

Bahcecioglu I, Tawheed A, Tunc N, Artas H, Madkour A, Cicek S J Clin Exp Hepatol. 2024; 14(6):101476.

PMID: 39113686 PMC: 11301361. DOI: 10.1016/j.jceh.2024.101476.


Triclabendazole Treatment Failure for Fasciola hepatica Infection among Preschool and School-Age Children, Cusco, Peru.

Morales M, Tanabe M, White Jr A, Lopez M, Bascope R, Cabada M Emerg Infect Dis. 2021; 27(7):1850-1857.

PMID: 34152949 PMC: 8237897. DOI: 10.3201/eid2707.203900.

References
1.
Valero M, Girones N, Garcia-Bodelon M, Periago M, Chico-Calero I, Khoubbane M . Anaemia in advanced chronic fasciolosis. Acta Trop. 2008; 108(1):35-43. DOI: 10.1016/j.actatropica.2008.08.007. View

2.
Marcos L, Maco V, Samalvides F, Terashima A, Espinoza J, Gotuzzo E . Risk factors for Fasciola hepatica infection in children: a case-control study. Trans R Soc Trop Med Hyg. 2005; 100(2):158-66. DOI: 10.1016/j.trstmh.2005.05.016. View

3.
Ulger B, Kapan M, Boyuk A, Uslukaya O, Oguz A, Bozdag Z . Fasciola hepatica infection at a University Clinic in Turkey. J Infect Dev Ctries. 2014; 8(11):1451-5. DOI: 10.3855/jidc.5124. View

4.
Esteban J, Bargues M . Epidemiology of human fascioliasis: a review and proposed new classification. Bull World Health Organ. 1999; 77(4):340-6. PMC: 2557647. View

5.
Valero M, Periago M, Perez-Crespo I, Rodriguez E, Perteguer M, Garate T . Assessing the validity of an ELISA test for the serological diagnosis of human fascioliasis in different epidemiological situations. Trop Med Int Health. 2012; 17(5):630-6. DOI: 10.1111/j.1365-3156.2012.02964.x. View